(Q48111569)

English

HIV-1 tropism for the central nervous system: Brain-derived envelope glycoproteins with lower CD4 dependence and reduced sensitivity to a fusion inhibitor

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/16309726

HIV-1 tropism for the central nervous system: Brain-derived envelope glycoproteins with lower CD4 dependence and reduced sensitivity to a fusion inhibitor (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/16309726

Matthew L Plassmeyer

4

object named as

Matthew L Plassmeyer

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/16309726

author name string

Julio Martín-García

1

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/16309726

Wei Cao

2

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/16309726

Angel Varela-Rohena

3

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/16309726

Francisco González-Scarano

5

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/16309726

language of work or name

0 references

publication date

23 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/16309726

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/16309726

346

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/16309726

1

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/16309726

169-179

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/16309726

Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Antigenically distinct conformations of CXCR4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Mature microglia resemble immature antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Early viral brain invasion in iatrogenic human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Direct ex vivo flow cytometric analysis of human microglial cell CD4 expression: examination of central nervous system biopsy specimens from HIV-seropositive patients and patients with other neurological disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

The neuropathogenesis of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Variability of critical epitopes within HIV-1 heptad repeat domains for selected entry inhibitors in HIV-infected populations worldwide [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Determinants of human immunodeficiency virus type 1 baseline susceptibility to the fusion inhibitors enfuvirtide and T-649 reside outside the peptide interaction site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Novel therapies based on mechanisms of HIV-1 cell entry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Mode of action of an antiviral peptide from HIV-1. Inhibition at a post-lipid mixing stage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

HIV fusion and its inhibition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

T-1249 retains potent antiretroviral activity in patients who had experienced virological failure while on an enfuvirtide-containing treatment regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

The role of host immunocompetence in neuroinvasion of Sindbis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Chemokine receptors in the brain: their role in HIV infection and pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Human immunodeficiency virus-associated dementia: an evolving disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Genotype and phenotype patterns of human immunodeficiency virus type 1 resistance to enfuvirtide during long-term treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enh

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Human microglial cells: Characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

HIV receptors within the brain: a study of CD4 and MHC-II on human neurons, astrocytes and microglial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Impact of mutations in the coreceptor binding site on human immunodeficiency virus type 1 fusion, infection, and entry inhibitor sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

HIV-associated cognitive impairment before and after the advent of combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Multinucleated giant cells and HTLV-III in AIDS encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Dimerization of chemokine receptors and its functional consequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: a Y-chromosome specific in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.031

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.10.031

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/16309726

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/16309726

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48111569&oldid=2185540000"